Infliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot study

Only your doctor can recommend a course of treatment after checking your health condition. REMICADE ® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE ® .

All patients with ulcerative colitis who are at increased risk for dysplasia or colon carcinoma (for example, patients with long-standing ulcerative colitis or primary sclerosing cholangitis), or who had a prior history of dysplasia or colon carcinoma should be screened for dysplasia at regular intervals before therapy and throughout their disease course. This evaluation should include colonoscopy and biopsies per local recommendations. With current data it is not known if infliximab treatment influences the risk for developing dysplasia or colon cancer (see section ).

The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.

Infliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot study

infliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot study

Media:

infliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot studyinfliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot studyinfliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot studyinfliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot studyinfliximab in the treatment of severe steroid-refractory ulcerative colitis a pilot study

http://buy-steroids.org